Skip to main content

Advertisement

SpringerLink
Log in

Simultane Radiochemotherapie zur Behandlung solider Tumoren

Concurrent radiochemotherapy for the treatment of solid tumors

  • Originalien
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Ajani JA, Winter KA, Gunderson LL et al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299:1914–1921

    Article  PubMed  CAS  Google Scholar 

  2. Alani S, Soyfer V, Strauss N et al (2009) Limited advantages of intensity-modulated radiotherapy over 3D conformal radiation therapy in the adjuvant management of gastric cancer. Int J Radiat Oncol Biol Phys 74:562–566

    Article  PubMed  Google Scholar 

  3. Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol;16:1310–1317

    Google Scholar 

  4. Ang KK, Zhang QE, Rosenthal DI et al (2011) A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). J Clin Oncol 29:(suppl; abstr 5500)

  5. Auperin A, Le Pechoux C, Rolland E et al (2010) Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28:2181–2190

    Article  PubMed  CAS  Google Scholar 

  6. Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049

    PubMed  CAS  Google Scholar 

  7. Bartelink H, Schellens JH, Verheij M (2002) The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer 38:216–222

    Article  PubMed  CAS  Google Scholar 

  8. Bazan JG, Hara W, Hsu A et al (2011) Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer 117:3342–3351

    Article  PubMed  Google Scholar 

  9. Bentzen BH, Harari PM, Bernier J (2007) Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions. Nat Clin Pract Oncol 4:172–180

    Article  PubMed  Google Scholar 

  10. Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952

    Article  PubMed  CAS  Google Scholar 

  11. Bernier J, Bonner J, Vermorken JB et al (2008) Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 19:142–149

    Article  PubMed  CAS  Google Scholar 

  12. Blanchard P, Baujat B, Holostenco V et al (2011) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 100:33–40

    Article  PubMed  Google Scholar 

  13. Boda-Heggemann J, Hofheinz RD, Weiss C et al (2009) Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer. Int J Radiat Oncol Biol Phys 75:1187–1195

    Article  PubMed  Google Scholar 

  14. Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578

    Article  PubMed  CAS  Google Scholar 

  15. Brunner T, McKenna G (2011) Combining molecular targeted therapeutics (MTT) and radiotherapy: MTT and MTD. Eur J Cancer 47(Suppl 3):373–374

    Article  Google Scholar 

  16. Budach V, Stuschke M, Budach W et al. (2005) Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23:1125–1135

    Article  PubMed  CAS  Google Scholar 

  17. Cohen EEW, Karrison T, Kocherginsky M et al (2012) DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol 30:(suppl; abstr 5500)

  18. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623–1627

    Article  PubMed  CAS  Google Scholar 

  19. Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944

    Article  PubMed  Google Scholar 

  20. Crane CH, Winter K, Regine WF et al (2009) Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. J Clin Oncol 27:4096–4102

    Article  PubMed  CAS  Google Scholar 

  21. Crane CH, Eng C, Feig BW et al (2010) Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 76:824–830

    Article  PubMed  CAS  Google Scholar 

  22. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20

    Article  PubMed  CAS  Google Scholar 

  23. Curran WJ Jr, Paulus R, Langer CJ et al (2011) Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 103:1452–1460

    Article  PubMed  CAS  Google Scholar 

  24. Dewdney A, Cunningham D, Tabernero J et al (2012) Multicenter randomized phase ii clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). J Clin Oncol 30:1620–1627

    Article  PubMed  CAS  Google Scholar 

  25. Dunst J, Reichard U, Wolf N et al (1987) Function-preserving treatment of anal cancer using simultaneous radio- and chemotherapy. Dtsch Med Wochenschr 112:1201–1205

    Article  PubMed  CAS  Google Scholar 

  26. Eisbruch A, Kim HM, Feng FY et al (2011) Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 81:e93–e99

    Article  PubMed  Google Scholar 

  27. Fietkau R, Iro H, Grabenbauer GG et al (1991) Simultaneous radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in advanced head and neck tumors. Strahlenther Onkol 167:693–700

    PubMed  CAS  Google Scholar 

  28. Fietkau R, Sauer R (2002) Early irradiation with radiochemotherapy for limited-stage small cell lung cancer is superior to late irradiation. Strahlenther Onkol 178:585–588

    PubMed  Google Scholar 

  29. Fietkau R, Lautenschläger C, Sauer R et al (2006) Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: results of the German phase III trial ARO 96-3. J Clin Oncol 18:5507

    Google Scholar 

  30. Fietkau R, Semrau S (2010) Stage III: definitive chemoradiotherapy. Front Radiat Ther Oncol 42:122–134

    Article  PubMed  Google Scholar 

  31. Flam M, John M, Pajak TF et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527–2539

    PubMed  CAS  Google Scholar 

  32. Fournel P, Robinet G, Thomas P et al (2005) Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d’Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 23:5910–5917

    Article  PubMed  CAS  Google Scholar 

  33. Furuse K, Fukuoka M, Kawahara M et al (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692–2699

    PubMed  CAS  Google Scholar 

  34. Gastrointestinal Tumor Study Group (GITSG) (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465–1472

    Article  Google Scholar 

  35. Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234

    Article  PubMed  CAS  Google Scholar 

  36. Gunnlaugsson A, Kjellen E, Nilsson P et al (2007) Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer. Acta Oncol 46:937–944

    Article  PubMed  CAS  Google Scholar 

  37. Gurtner K, Deuse Y, Butof R et al (2011) Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression. Radiother Oncol 99:323–330

    Article  PubMed  CAS  Google Scholar 

  38. Haddad RI, Rabinowits G, Tishler RB et al (2012) The PARADIGM trial: a phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC). J Clin Oncol 30:(suppl; abstr 5501)

  39. Halpern J (1915) Experimenteller Beitrag zur Chemotherapie der Tiergeschwülste. Bd. 5 der Strahlentherapie

  40. Hofheinz RD, Wenz F, Post S et al (2012) Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol 13:579–588

    Article  PubMed  CAS  Google Scholar 

  41. Hustu HO, Holton C, James D Jr et al (1968) Treatment of Ewing’s sarcoma with concurrent radiotherapy and chemotherapy. J Pediatr 73:249–251

    Article  PubMed  CAS  Google Scholar 

  42. Jaffe N, Paed D, Traggis D et al (1976) Improved outlook for Ewing’s sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy. Cancer 38:1925–1930

    Article  PubMed  CAS  Google Scholar 

  43. Jeremic B, Shibamoto Y, Acimovic L et al (1996) Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14:1065–1070

    PubMed  CAS  Google Scholar 

  44. Klautke G, Fietkau R (2007) Intensified neoadjuvant radiochemotherapy for locally advanced rectal cancer: a review. Int J Colorectal Dis 22:457–465

    Article  PubMed  Google Scholar 

  45. Klautke G, Sauer R, Fietkau R (2008) Combined treatment modality in small cell lung cancer: the impact of radiotherapy on survival. Strahlenther Onkol 184:61–66

    Article  PubMed  Google Scholar 

  46. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

    Article  PubMed  CAS  Google Scholar 

  47. Morris M, Eifel PJ, Lu J et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143

    Article  PubMed  CAS  Google Scholar 

  48. Niyazi M, Maihoefer C, Krause M et al (2011) Radiotherapy and „new“ drugs-new side effects? Radiat Oncol 6:177

    Article  PubMed  CAS  Google Scholar 

  49. Peters WA III, Liu PY, Barrett RJ II et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–1613

    PubMed  CAS  Google Scholar 

  50. Pignon JP, le Maitre A, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14

    Article  PubMed  Google Scholar 

  51. Rodel C, Liersch T, Becker H et al (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 13:679–687

    Article  PubMed  Google Scholar 

  52. Rose PG (2002) Chemoradiotherapy for cervical cancer. Eur J Cancer 38:270–278

    Article  PubMed  CAS  Google Scholar 

  53. Sauer R, Schrott KM, Dunst J et al (1988) Preliminary results of treatment of invasive bladder carcinoma with radiotherapy and cisplatin. Int J Radiat Oncol Biol Phys 15:871–875

    Article  PubMed  CAS  Google Scholar 

  54. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740

    Article  PubMed  CAS  Google Scholar 

  55. Sauer R, Liersch T, Merkel S et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years. J Clin Oncol 30:1926–1933

    Article  PubMed  CAS  Google Scholar 

  56. Schaake-Koning C, Bogaert W van den, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524–530

    Article  PubMed  CAS  Google Scholar 

  57. Smith TJ, Ryan LM, Douglass HO Jr et al (1998) Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42:269–276

    Article  PubMed  CAS  Google Scholar 

  58. Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5:85–91

    Article  PubMed  CAS  Google Scholar 

  59. Stehman FB, Ali S, Keys HM et al (2007) Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial. Am J Obstet Gynecol 197:503 e1–e6

    Article  PubMed  Google Scholar 

  60. Stupp R, Mason WP, Bent MJ van den et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

    Article  PubMed  CAS  Google Scholar 

  61. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

    Article  PubMed  CAS  Google Scholar 

  62. Thomas PR, Lindblad AS (1988) Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol 13:245–252

    Article  PubMed  CAS  Google Scholar 

  63. Tosch U, Wendt TG, Rohloff R et al (1988) Simultaneous radio- and chemotherapy of squamous cell carcinoma of the esophagus. Strahlenther Onkol 164:214–218

    PubMed  CAS  Google Scholar 

  64. Tveit KM, Guldvog I, Hagen S et al (1997) Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 84:1130–1135

    Article  PubMed  CAS  Google Scholar 

  65. UK Co-ordinating Committee on Cancer Research (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. Lancet 348:1049–1054

    Article  Google Scholar 

  66. Van Den Bent MJ, Hoang-Xuan K, Brandes AA et al (2012) Long-term follow-up results of EORTC 26951: a randomized phase III study on adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors (AOD). J Clin Oncol 30:(suppl; abstr 2)

  67. Vogelius IS, Westerly DC, Cannon GM et al (2011) Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping. Int J Radiat Oncol Biol Phys 80:893–899

    Article  PubMed  Google Scholar 

  68. Vokes EE, Herndon JE III, Crawford J et al (2002) Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol 20:4191–4198

    Article  PubMed  CAS  Google Scholar 

  69. Willett CG, Duda DG, Tomaso E di et al (2007) Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol 4:316–321

    Article  PubMed  CAS  Google Scholar 

  70. Willett CG, Duda DG, Tomaso E di et al (2009) Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol 27:3020–3026

    Article  PubMed  CAS  Google Scholar 

  71. Wobbes T, Baron B, Paillot B et al (2001) Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 37:470–477

    Article  PubMed  CAS  Google Scholar 

  72. Wong R, Malthaner R (2006) Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev CD002092

  73. Ychou M, Boige V, Pignon JP et al (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29:1715–1721

    Article  PubMed  CAS  Google Scholar 

  74. Zamboglou N, Pape H, Schnabel T et al (1989) Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors. Strahlenther Onkol 165:647–651

    PubMed  CAS  Google Scholar 

  75. Zatloukal P, Petruzelka L, Zemanova M et al (2004) Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46:87–98

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Erlangen University Hospital, Universitätsstr. 27, 91054, Erlangen, Deutschland

    R. Fietkau

Authors
  1. R. Fietkau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Fietkau.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fietkau, R. Simultane Radiochemotherapie zur Behandlung solider Tumoren. Strahlenther Onkol 188 (Suppl 3), 263–271 (2012). https://doi.org/10.1007/s00066-012-0194-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-012-0194-0

Search

Navigation